Evidence-Based Medicine Guidelines
Omalizumab for asthma
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Omalizumab for Asthma." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/455460/all/Omalizumab_for_asthma.
Omalizumab for asthma. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/455460/all/Omalizumab_for_asthma. Accessed October 14, 2024.
Omalizumab for asthma. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/455460/all/Omalizumab_for_asthma
Omalizumab for Asthma [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2024 October 14]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/455460/all/Omalizumab_for_asthma.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Omalizumab for asthma
ID - 455460
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/455460/all/Omalizumab_for_asthma
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
